lomustine has been researched along with Histiocytic Sarcoma in 12 studies
Histiocytic Sarcoma: Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aims of this study were to report treatment outcomes for dogs with histiocytic sarcoma (HS) treated with both lomustine and epirubicin, and to report response rates to epirubicin as a rescue therapy in dogs previously treated with lomustine." | 7.88 | Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy. ( Blackwood, L; Finotello, R; Mason, SL, 2018) |
| "To describe a chemotherapy protocol combining lomustine and doxorubicin in canine histiocytic sarcoma, including outcomes and toxicity." | 7.81 | Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma. ( Borgatti, A; Cannon, C; Henson, M; Husbands, B, 2015) |
| "Lomustine is a well-accepted, first-line chemotherapy for dogs with HS, but its specific utility in dogs with HPHS has not been previously reported." | 5.48 | Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers. ( Elliott, J, 2018) |
| "The aims of this study were to report treatment outcomes for dogs with histiocytic sarcoma (HS) treated with both lomustine and epirubicin, and to report response rates to epirubicin as a rescue therapy in dogs previously treated with lomustine." | 3.88 | Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy. ( Blackwood, L; Finotello, R; Mason, SL, 2018) |
| "To describe a chemotherapy protocol combining lomustine and doxorubicin in canine histiocytic sarcoma, including outcomes and toxicity." | 3.81 | Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma. ( Borgatti, A; Cannon, C; Henson, M; Husbands, B, 2015) |
| "Primary pulmonary histiocytic sarcoma (PHS) is a rare form of dendritic cell or macrophage neoplasia originating within the pulmonary parenchyma." | 1.72 | Outcome in dogs with curative-intent treatment of localized primary pulmonary histiocytic sarcoma. ( Al-Nadaf, S; Clifford, C; Cook, MR; De Mello Souza, CH; Herrera, CL; Husbands, B; Krick, E; Leeper, H; McMillan, S; Murray, CA; Pellin, M; Richardson, D; Skorupski, KA; Willcox, JL, 2022) |
| "Lomustine is a well-accepted, first-line chemotherapy for dogs with HS, but its specific utility in dogs with HPHS has not been previously reported." | 1.48 | Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers. ( Elliott, J, 2018) |
| "Multifocal histiocytic sarcoma with a spindle-cell pattern was diagnosed based on morphologic features and intense expression of CD18." | 1.38 | Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping. ( Aubry, OA; Christopherson, PW; Kennis, RA; Mastrorilli, C; Moore, PF; Newton, JC; Smith, AN; Spangler, EA; Weismann, JL, 2012) |
| "This is the first case of histiocytic sarcoma in a cat to be reported in Japan." | 1.35 | Disseminated histiocytic sarcoma with excessive hemophagocytosis in a cat. ( Fujino, Y; Ide, K; Nakagawa, T; Nakayama, H; Ohno, K; Setoguchi-Mukai, A; Tsujimoto, H; Uetsuka, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, CA | 1 |
| Willcox, JL | 1 |
| De Mello Souza, CH | 1 |
| Husbands, B | 2 |
| Cook, MR | 1 |
| Clifford, C | 1 |
| Leeper, H | 1 |
| Pellin, M | 1 |
| Richardson, D | 1 |
| Herrera, CL | 1 |
| Krick, E | 1 |
| McMillan, S | 1 |
| Al-Nadaf, S | 1 |
| Skorupski, KA | 2 |
| Patten, S | 1 |
| MacKenzie, S | 1 |
| Soileau, AM | 1 |
| Neto, RLALT | 1 |
| Jimenez, PT | 1 |
| Hamersky, J | 1 |
| Smith, AA | 1 |
| Purzycka, K | 1 |
| Peters, LM | 1 |
| Elliott, J | 2 |
| Lamb, CR | 1 |
| Priestnall, SL | 1 |
| Hardas, A | 1 |
| Johnston, CA | 1 |
| Rodriguez-Piza, I | 1 |
| Mason, SL | 1 |
| Finotello, R | 1 |
| Blackwood, L | 1 |
| Jackson, AE | 1 |
| Cannon, C | 1 |
| Borgatti, A | 1 |
| Henson, M | 1 |
| Yamazaki, H | 1 |
| Takagi, S | 1 |
| Hosoya, K | 1 |
| Okumura, M | 1 |
| Rodriguez, CO | 1 |
| Krick, EL | 1 |
| Clifford, CA | 1 |
| Ward, R | 1 |
| Kent, MS | 1 |
| Ide, K | 1 |
| Setoguchi-Mukai, A | 1 |
| Nakagawa, T | 1 |
| Uetsuka, K | 1 |
| Nakayama, H | 1 |
| Fujino, Y | 1 |
| Ohno, K | 1 |
| Tsujimoto, H | 1 |
| Mastrorilli, C | 1 |
| Spangler, EA | 1 |
| Christopherson, PW | 1 |
| Aubry, OA | 1 |
| Newton, JC | 1 |
| Smith, AN | 1 |
| Kennis, RA | 1 |
| Weismann, JL | 1 |
| Moore, PF | 1 |
12 other studies available for lomustine and Histiocytic Sarcoma
| Article | Year |
|---|---|
Outcome in dogs with curative-intent treatment of localized primary pulmonary histiocytic sarcoma.
Topics: Animals; Dog Diseases; Dogs; Histiocytic Sarcoma; Lomustine; Lung; Lung Neoplasms; Retrospective Stu | 2022 |
Prolonged Survival Following Treatment of Histiocytic Sarcoma of the Canine Urinary Bladder.
Topics: Animals; Dog Diseases; Dogs; Doxorubicin; Histiocytic Sarcoma; Lomustine; Male; Urinary Bladder | 2022 |
Doxorubicin and zoledronate treatment in a dog with hemophagocytic histiocytic sarcoma.
Topics: Animals; Dog Diseases; Dogs; Doxorubicin; Histiocytic Sarcoma; Hyperbilirubinemia; Hypoalbuminemia; | 2023 |
Histiocytic sarcoma in miniature schnauzers: 30 cases.
Topics: Animals; Dog Diseases; Dogs; Histiocytic Sarcoma; Lomustine; Retrospective Studies | 2020 |
Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Epirubicin; Female; Histiocytic Sarcoma; Lomusti | 2018 |
Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
Topics: Animals; Antineoplastic Agents, Alkylating; Dog Diseases; Dogs; Histiocytic Sarcoma; Lomustine; Lymp | 2018 |
In this issue - December 2018: Pro bono wildlife work in Australian veterinary practices · Roaming owned dogs in Northern Australia · Snake stomach recovers after gastrectomy · Metronidazole-induced neurotoxicity in 26 dogs · Lomustine ineffective for hae
Topics: Animal Welfare; Animals; Australia; Dogs; Gastrectomy; Histiocytic Sarcoma; Lomustine; Metronidazole | 2018 |
Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; | 2015 |
Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dog Diseases; Dogs; Drug Resistance, N | 2015 |
Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
Topics: Animals; Antineoplastic Agents; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Dog D | 2009 |
Disseminated histiocytic sarcoma with excessive hemophagocytosis in a cat.
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Fatal Outcome; Female; Histiocytic S | 2009 |
Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping.
Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Antineoplastic Agents; Biopsy, Fine-Needle; Cephalexin | 2012 |